✦ LIBER ✦

96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B

✍ Scribed by Chee-Kin Hui; Hai-Ying Zhang; Scott Bowden; Stephen Locarnini; John M. Luk; Kar-Wai Leung; Yui-Hung Yueng; April Wong; Frank Rousseau; Kwok-Yung Yuen; Nikolai N. Naoumov; George K.K. Lau

Book ID: 116651493
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 140 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2007.10.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “96 weeks combination of

Corrigendum to “96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B”: J Hepatol 48 (2008) 714–720

✍ Chee-Kin Hui; Hai-Ying Zhang; Scott Bowden; Stephen Locarnini; John M. Luk; Kar- 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

PL-009 Combination of telbivudine and ad

PL-009 Combination of telbivudine and adefovir dipivoxil therapy in chronic hepatitis B patients with poor response to adefovir dipivoxil monotherapy

✍ E.-Q. Chen; T.-Y. Zhou; H. Tang 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Comparative meta-analysis of adefovir di

Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B

✍ YongFa Chen; Ting Ju 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 1004 KB

Efficacy and safety of telbivudine plus

Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil

✍ Lu, Jia-Jie; Liu, Kai; Ma, Yuan-Ji; Wang, Juan; Chen, En-Qiang; Tang, Hong 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Adefovir dipivoxil in the treatment of c

Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection

✍ Hadziyannis, Stephanos J ;Papatheodoridis, George V 📂 Article 📅 2004 🏛 Expert Reviews 🌐 English ⚖ 179 KB

Increased risk of adefovir resistance in

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy

✍ Yoon-Seon Lee; Dong Jin Suh; Young-Suk Lim; Suk Won Jung; Kang Mo Kim; Han Chu L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

Although adefovir dipivoxil (ADV) has a unique profile of delayed and infrequent resistance in treatment-naïve chronic hepatitis B patients, the association of ADV resistance with previous lamivudine (LAM) resistance is not well understood. We compared the emergence of the ADV-resistant mutations rt